Cubist Acquisition Payments Targeted In FCPA Probe
By Stephanie Russell-Kraft ( August 12, 2014, 5:42 PM EDT) -- Cubist Pharmaceuticals Inc. revealed Monday that a global biopharmaceutical company it bought in 2013 is under investigation by the U.S. Securities and Exchange Commission and U.S. Department of Justice over improper payments made to a research laboratory in 2011 that may have violated the Foreign Corrupt Practices Act....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.